When a drug has been approved by Health Canada, when preauthorization trials have been done and it is being sold on the market, do pharmaceutical companies continue to conduct studies on the drug, or do they wait until adverse effects have been reported by the public before more investigation is done?
On June 12th, 2014. See this statement in context.